CryoLife Inc Stock News

Vasamed (OTCMKTS:VSMD) and CryoLife (NYSE:CRY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings. Analyst Ratings This is a summary of recent recommendations and price targets for Vasamed and CryoLife, as provided []

New York State Teachers Retirement System lowered its stake in shares of CryoLife, Inc. (NYSE:CRY) by 0.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 88,257 shares of the medical equipment providers stock after selling 700 shares during the quarter. New York State Teachers Retirement Systems holdings in CryoLife were worth $1,967,000 as []

CryoLife, Inc. (NYSE:CRY) CAO Amy Horton sold 2,500 shares of CryoLife stock in a transaction dated Wednesday, December 8th. The shares were sold at an average price of $18.57, for a total value of $46,425.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. []

DUBLIN--(BUSINESS WIRE)--The "Medical Adhesives and Sealants - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com''s offering. Amid the COVID-19 crisis, the global market for Medical Adhesives and Sealants estimated at US$10.3 Billion in the year 2020, is projected to reach a revised size of US$15.2 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Acrylic, one of the segments analyzed in the report, is projected to record a 4.7

State of Alaska Department of Revenue lifted its holdings in CryoLife, Inc. (NYSE:CRY) by 6.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,672 shares of the medical equipment providers stock after acquiring an additional 1,615 shares during the period. State of Alaska Department of Revenues []

Invesco Ltd. raised its stake in CryoLife, Inc. (NYSE:CRY) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 223,217 shares of the medical equipment providers stock after purchasing an additional 897 shares during the period. Invesco Ltd. owned approximately []

Key Companies Covered in the Regenerative Medicine Market Research Report Are Amgen Inc., Novartis AG, Medtronic Plc., Stryker Corporation, CryoLife, Inc., Integra LifeSciences Corporation, 3M Company, AbbVie Inc., Zimmer Biomet, and other key market players. Key Companies Covered in the Regenerative Medicine Market Research Report Are Amgen Inc., Novartis AG, Medtronic Plc., Stryker Corporation, CryoLife, Inc., Integra LifeSciences Corporation, 3M Company, AbbVie Inc., Zimmer Biomet, and other key market players.

Cryolife, Inc. (CRY) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $720M. The stock is currently down 22.4% year-to-date, down 13.5% over the past 12 months, and down 6.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 22.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 7858.6% The company's stock price performance over the past 12 months lags the peer average by -273.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 923.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cryolife, Inc. (CRY) shares closed today at 0.9% above its 52 week low of $18.15, giving the company a market cap of $740M. The stock is currently down 20.2% year-to-date, down 10.7% over the past 12 months, and down 6.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Trading volume this week was 25.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -714.9% The company's stock price performance over the past 12 months lags the peer average by -186.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 913.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Bank of America Corp DE reduced its position in shares of CryoLife, Inc. (NYSE:CRY) by 8.3% in the second quarter, Holdings Channel reports. The firm owned 275,511 shares of the medical equipment providers stock after selling 24,975 shares during the quarter. Bank of America Corp DEs holdings in CryoLife were worth $7,824,000 as of its []

Bank of America Corp DE trimmed its stake in CryoLife, Inc. (NYSE:CRY) by 8.3% in the 2nd quarter, HoldingsChannel reports. The firm owned 275,511 shares of the medical equipment providers stock after selling 24,975 shares during the quarter. Bank of America Corp DEs holdings in CryoLife were worth $7,824,000 at the end of the most []

CryoLife with ticker code (CRY) have now 4 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 39 and 29 calculating the average target price we see 33.44. Now with the previous closing price of 18.95 this now indicates there is a potential upside of 76.5%. There is a 50 day moving average of 21.84 and the 200 day MA is 25.15. The company has a market capitalisation of $741m. Find out more information at: /> [stock_market_widget type="chart" symbol="CRY" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] CryoLife manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system.

Thrivent Financial for Lutherans cut its holdings in CryoLife, Inc. (NYSE:CRY) by 16.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 96,638 shares of the medical equipment providers stock after selling 19,200 shares during the quarter. Thrivent Financial for Lutherans owned 0.25% of []

Hemostatic Wound Dressing Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist

Value investors may find the following stocks to be attractive opportunities, as they have low price-sales ratios compared to the S&P 500 and good profitability.